Guardant Health
Steve Krognes has extensive experience in financial leadership and governance, currently serving as Chief Financial Officer and Board Member at Denali Therapeutics since October 2015. Krognes holds multiple Board Member positions at various organizations, including Pliant Therapeutics, HBS Healthcare Alumni Association, ClavystBio, argenx, and Guardant Health. Previously, Krognes was a Board Member at Gritstone bio, Corvus Pharmaceuticals, and the California Life Science Association. Between June 2014 and June 2018, Krognes served as a Trustee on the Board of Trustees for the California Academy of Sciences. Krognes holds an MBA in Finance from Harvard Business School and a Bachelor of Science in Finance from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Guardant Health
14 followers
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum.